72.11.Z - Scientific research and development activities
01.19.Z - Other crop production not including perennials
10.41.Z - Production of oils and other liquid fats
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
28.99.Z - Manufacture of other special-purpose machinery not elsewhere classified
32.99.Z - Production of other products not classified elsewhere
46 - Wholesale trade
71.12.Z - Engineering activities and related technical consultancy
71.2 - Technical testing and analysis
72.19.Z - Scientific research and development activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,2 | -0,2 | -0,1 | 59,4 |
EBITDA | -0,2 | -0,2 | -0,1 | 59,5 |
Short time liabilities | 0,8 | 1,1 | 1,8 | 58,6 |
Equity capital | 1,1 | 1 | 0,9 | -7,5 |
Operating profit (EBIT) | -0,2 | -0,2 | -0,1 | 58,1 |
Assets | 4,7 | 5,3 | 5,6 | 5,5 |
Net profit (loss) | -0,2 | -0,2 | -0,1 | 59,4 |
Cash | 2,4 | 1,1 | 0,1 | -95,4 |
Liabilities and provisions for liabilities | 3,6 | 4,3 | 4,7 | 8,4 |
Net income from sale | 0 | 0 | 0 | -∞ |
Working assets | 4,5 | 4,8 | 5 | 3,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -15,9 | -18,5 | -8,1 | 10,4 |
Equity capital to total assets | 24,1 | 18,2 | 16 | -2,2 |
Gross profit margin | -497,8 | |||
EBITDA Margin | -467,6 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 44 813 | -2 147 438 835 |
Current financial liquidity indicator | 1.266150951385498 | 1.1181247234344482 | 1.0695955753326416 | 0 |
Net dept to EBITDA | 13.677878379821777 | 6.720114707946777 | 0.7585543990135193 | -5,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane